A number of small sample studies suggest that removal of B cells is effective for treating refractory ANM-SRP [26], while this study also provided pathological evidence for the use of B lymphocyte depletion drugs and suggested that BAFF inhibitors [27] may be effective in the treatment of patients with ANM-SRP. Here, TNFSF13B is linked to short rib dysplasia.